<code id='CD5178B027'></code><style id='CD5178B027'></style>
    • <acronym id='CD5178B027'></acronym>
      <center id='CD5178B027'><center id='CD5178B027'><tfoot id='CD5178B027'></tfoot></center><abbr id='CD5178B027'><dir id='CD5178B027'><tfoot id='CD5178B027'></tfoot><noframes id='CD5178B027'>

    • <optgroup id='CD5178B027'><strike id='CD5178B027'><sup id='CD5178B027'></sup></strike><code id='CD5178B027'></code></optgroup>
        1. <b id='CD5178B027'><label id='CD5178B027'><select id='CD5178B027'><dt id='CD5178B027'><span id='CD5178B027'></span></dt></select></label></b><u id='CD5178B027'></u>
          <i id='CD5178B027'><strike id='CD5178B027'><tt id='CD5178B027'><pre id='CD5178B027'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:7
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Dark money group runs ads on China biotech bill
          Dark money group runs ads on China biotech bill

          BGIGrouphasbeentargetedbyadarkmoneygroupsupportingtheBIOSECUREAct.STR/AFPviaGettyImagesYou’rereading

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Latest bird flu infection made farmworker sicker than earlier cases

          BRENDANSMIALOWSKI/AFPviaGettyImagesAthirdhumancaseofH5birdflutiedtotheongoingU.S.outbreakincattlehas